Magali Taiel

Chief Tech/Sci/R&D Officer at GENSIGHT BIOLOGICS S.A.

Health Technology

Consumer Services

Commercial Services

Profile

Dr. Magali Taiel, MD, is a Chief Medical Officer at Gensight Biologics SA. Dr. Taiel was previously employed as a Vice President-Clinical Development by ProQR Therapeutics NV and a Project Manager by Servier SAS.
She received her doctorate degree from Universite Paris Cite.

Magali Taiel active positions

Companies	Position	Start
GENSIGHT BIOLOGICS S.A.	Chief Tech/Sci/R&D Officer	2019-10-07

All active positions of Magali Taiel

Former positions of Magali Taiel

Companies	Position	End
PROQR THERAPEUTICS N.V.	Corporate Officer/Principal	2018-08-31
Servier SAS Servier SAS Miscellaneous Commercial ServicesCommercial Services Servier SAS is based in Suresnes, France and has a global presence of subsidiaries in several regions. The French company chooses to reinvest its profits in the discovery of new drugs and is recognized for its quality and medical excellence. The company works with patients at all stages of the drug life cycle to provide them with the most suitable care paths. Servier specializes in research on cardiovascular disease, cancer, diabetes, immuno-inflammatory, and neuro-psychiatric diseases. Servier SAS is a pharmaceutical company that was founded in 1954.	Corporate Officer/Principal	2000-12-31

See the detail of Magali Taiel's experience

Training of Magali Taiel

Universite Paris Cite

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Magali Taiel's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
GENSIGHT BIOLOGICS S.A.	Health Technology
PROQR THERAPEUTICS N.V.	Health Technology

Private companies	1
Servier SAS Servier SAS Miscellaneous Commercial ServicesCommercial Services Servier SAS is based in Suresnes, France and has a global presence of subsidiaries in several regions. The French company chooses to reinvest its profits in the discovery of new drugs and is recognized for its quality and medical excellence. The company works with patients at all stages of the drug life cycle to provide them with the most suitable care paths. Servier specializes in research on cardiovascular disease, cancer, diabetes, immuno-inflammatory, and neuro-psychiatric diseases. Servier SAS is a pharmaceutical company that was founded in 1954.	Commercial Services